Health
UTHSC receives $1.25 million to conduct a study on improving adherence to HPV vaccine – News-Medical.Net
The human papillomavirus (HPV) vaccine was introduced in the United States for preteens more than a dozen years ago, yet adherence rates are still below those for…
The human papillomavirus (HPV) vaccine was introduced in the United States for preteens more than a dozen years ago, yet adherence rates are still below those for other childhood vaccines. Researchers at the University of Tennessee Health Science Center and Emory University have received a major grant totaling $2.7 million from the National Cancer Institute/National Institutes of Health to conduct a five-year study aimed at developing methods to improve adherence to the HPV vaccine. UTHSC will receive…
-
Business18 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business14 hours agoDicker Data rides the AI trend to double digit growth
-
Business22 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Noosa News15 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference